We are live on ! Find out more
CTSO icon

Cytosorbents Corp

49 hedge funds and large institutions have $16.9M invested in Cytosorbents Corp in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

20% more capital invested

Capital invested by funds: $14.1M → $16.9M (+$2.81M)

14% more call options, than puts

Call options by funds: $8K | Put options by funds: $7K

2.93% more ownership

Funds ownership: 27.96%30.89% (+2.9%)

4% less funds holding

Funds holding: 5149 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
18
Reduced
9
Closed
9
Calls
$8K
Puts
$7K
Net Calls
+$1K
Net Calls Change
-$14K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
51
Millennium Management
New York
-$30.3K -33,280 Closed
OIA
52
OneDigital Investment Advisors
Kansas
-$13.7K -15,000 Closed
JIC
53
Johnson Investment Counsel
Ohio
-$10.5K -11,534 Closed
HF
54
HRT Financial
New York
-$10K -11,509 Closed
Jane Street
55
Jane Street
New York
-$9.23K -10,147 Closed
NWWA
56
New Wave Wealth Advisors
Arkansas
-$1.48K -1,631 Closed
Lazard Asset Management
57
Lazard Asset Management
New York
+$1K +954 New

CTSO Hedge Fund Activity: Q1 2025 in Review

49 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2025, worth a combined $16.9M — up 20% from $14.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CTSO and 7 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 18 added.

The largest buyer was Avenir Corporation, adding an estimated $2.06M. The largest seller was Granahan Investment Management, cutting an estimated $892K.

  • 49 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2025, down from 51 in Q4 2024.
  • Funds reported $16.9M of Cytosorbents Corp stock for Q1 2025, up 20% quarter-over-quarter.
  • 7 funds opened new Cytosorbents Corp positions in Q1 2025 and 9 closed out, a net change of -2 holders.
  • The largest Cytosorbents Corp buyer in Q1 2025 was Avenir Corporation, an estimated $2.06M added.
  • The largest Cytosorbents Corp seller in Q1 2025 was Granahan Investment Management, an estimated $892K sold.

Based on aggregated 13F filings for Q1 2025.